Author： Kim Tae Hyung Lee Seulki Chen Xiaoyuan
Publisher： Informa Healthcare
ISSN： 1473-7159
Source： Expert Review of Molecular Diagnostics, Vol.13, Iss.3, 2013-04, pp. : 257-269
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Nanotheranostics in Evidence Based Personalized Medicine
Current Drug Targets, Vol. 15, Iss. 10, 2014-09 ,pp. :
Access to resources
Recommend
Pharmacogenomic biomarkers for personalized medicine
By Chen James J Lin Wei-Jiun Chen Hung-Chia
Pharmacogenomics, Vol. 14, Iss. 8, 2013-06 ,pp. :
Personalized medicine: decades away?
By Lunshof Jeantine E Pirmohamed Munir Gurwitz David
Pharmacogenomics, Vol. 7, Iss. 2, 2006-03 ,pp. :
Pharmacometabonomics as an effector for personalized medicine
By Nicholson Jeremy K Wilson Ian D Lindon John C
Pharmacogenomics, Vol. 12, Iss. 1, 2011-01 ,pp. :
Privacy issues in personalized medicine
By Vaszar Laszlo T Cho Mildred K Raffin Thomas A
Pharmacogenomics, Vol. 4, Iss. 2, 2003-03 ,pp. :